Showing results (1781-1790 of 9,903) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|December 12, 2018
Real-life feasibility of salvage allogeneic transplantation in peripheral T-cell lymphomasAlberto Mussetti, Nicolò Martinetti, Nicoletta Cieri, et al.Bone Marrow Transplantation|March 16, 2018
Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host diseaseLambros Kordelas, Fabiola da Silva Nardi, Bettina Wagner, et al.Bone Marrow Transplantation|March 18, 2018
Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinibLotte van der Wagen, Liane Te Boome, Marleen Schiffler, et al.Bone Marrow Transplantation|March 18, 2018
Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous communityAmeera Gaafar, Atia Sheereen, Fahad Almohareb, et al.Bone Marrow Transplantation|June 6, 2022
Grading bloodstream infection risk using citrulline as a biomarker of intestinal mucositis in patients receiving intensive therapyC E M de Mooij, W J F M van der Velden, A F J de Haan, et al.Bone Marrow Transplantation|June 6, 2022
Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantationMasaharu Tamaki, Shimpei Matsumi, Hideki Nakasone, et al.Bone Marrow Transplantation|May 24, 2022
A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantationBorje S Andersson, Peter F Thall, Junsheng Ma, et al.Bone Marrow Transplantation|June 11, 2022
The cellular composition and function of the bone marrow niche after allogeneic hematopoietic cell transplantationFlavia Peci, Linde Dekker, Anna Pagliaro, et al.Bone Marrow Transplantation|July 6, 2022
Curative allogeneic hematopoietic stem cell transplantation following reduced toxicity conditioning in adults with primary immunodeficiencyAmbroise Marçais, Nizar Mahlaoui, Bénédicte Neven, et al.Bone Marrow Transplantation|June 28, 2022
Impact on outcomes of mixed chimerism of bone marrow CD34+ sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid malignanciesYannick Le Bris, Domitille Costes, Raphaël Bourgade, et al.Pageof 991